Nonprofits receive FDA approval for Chagas drug; Gilead’s buyout of Kite will put it back in pricing fray; most cancer patients don’t receive fertility info
Five things for pharma marketers to know: Monday, August 21, 2017
August 21, 2017
2:18 pm
The FDA approves Ironwood’s gout drug; GSW names new president; Samsung and Takeda to partner on biologic development
Five things for pharma marketers to know: Friday, August 4, 2017
The FDA approves osteoporosis drug; groups warn that latest healthcare bill would cut protections for pre-existing conditions; Dupixent gets PBM coverage
Five things for pharma marketers to know: Wednesday, April 12, 2017
The FDA approves first drug to treat tardive dyskinesia; Americans use crowdfund sites to pay for prescriptions; stroke sufferers struggle with adherence
Five things for pharma marketers to know: Thursday, April 6, 2017